We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
(-11%)
Cap. Flow
+$47.8M
Cap. Flow
% of AUM
7.17%
Top 10 Holdings %
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Relay Therapeutics
RLAY
|
+$3.83M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$3M |
| 3 |
Teck Resources
TECK
|
+$2.87M |
| 4 |
MODV
ModivCare
MODV
|
+$2.67M |
| 5 |
Genpact
G
|
+$2.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.07M |
| 2 |
CHS
Chicos FAS, Inc.
CHS
|
+$2.68M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$2.45M |
| 4 |
Crane NXT
CXT
|
+$2.44M |
| 5 |
ATCO
Atlas Corp.
ATCO
|
+$2.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.12% |
| 2 | Technology | 15.11% |
| 3 | Consumer Discretionary | 12.76% |
| 4 | Industrials | 12.53% |
| 5 | Financials | 11.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Hilltop Holdings
HTH
$2.24B
| $393K | 0.06% |
+14,745
| New | +$420K |
|
652
Advance Auto Parts
AAP
$3.49B
| $392K | 0.06% |
+2,264
| New | +$449K |
|
653
Mondelez International
MDLZ
$79.9B
| $392K | 0.06% |
+6,319
| New | +$399K |
|
654
Four Corners Property Trust
FCPT
$2.75B
| $391K | 0.06% |
14,696
-17,143
| -54% | -$467K |
|
655
BrightView Holdings
BV
$1.07B
| $390K | 0.06% |
32,504
-22,648
| -41% | -$284K |
|
656
COPT Defense Properties
CDP
$4.21B
| $390K | 0.06% |
+14,878
| New | +$402K |
|
|
VERV
657
DELISTED
Verve Therapeutics
VERV
| $390K | 0.06% |
+25,544
| New | +$396K |
|
658
Warrior Met Coal
HCC
$4.86B
| $389K | 0.06% |
12,693
-26,289
| -67% | -$911K |
|
|
CYBE
659
DELISTED
Cyberoptics Corp
CYBE
| $388K | 0.06% |
11,101
-8,790
| -44% | -$360K |
|
660
Belden
BDC
$5.19B
| $387K | 0.06% |
+7,263
| New | +$389K |
|
661
Winmark
WINA
$1.32B
| $387K | 0.06% |
+1,980
| New | +$406K |
|
662
Personalis
PSNL
$1.51B
| $385K | 0.06% |
111,704
+11,453
| +11% | +$58.3K |
|
663
Banc of California
BANC
$2.97B
| $384K | 0.06% |
21,795
+7,177
| +49% | +$131K |
|
664
Driven Brands
DRVN
$2.2B
| $384K | 0.06% |
13,952
-36,359
| -72% | -$993K |
|
665
Norfolk Southern
NSC
$75.1B
| $384K | 0.06% |
+1,691
| New | +$415K |
|
666
Advanced Energy
AEIS
$13B
| $383K | 0.06% |
+5,245
| New | +$406K |
|
667
Tidewater
TDW
$4.12B
| $383K | 0.06% |
18,174
-42,123
| -70% | -$969K |
|
668
Vulcan Materials
VMC
$36.9B
| $383K | 0.06% |
+2,692
| New | +$445K |
|
669
Deluxe
DLX
$1.15B
| $382K | 0.06% |
17,640
-3,677
| -17% | -$93.6K |
|
|
TGH
670
DELISTED
Textainer Group Holdings limited
TGH
| $382K | 0.06% |
+13,944
| New | +$450K |
|
671
The GEO Group
GEO
$4.1B
| $381K | 0.06% |
+57,739
| New | +$384K |
|
|
K
672
DELISTED
Kellanova
K
| $381K | 0.06% |
+5,684
| New | +$369K |
|
|
KALV
673
DELISTED
KalVista Pharmaceuticals
KALV
| $380K | 0.06% |
38,650
+15,148
| +64% | +$167K |
|
674
Sotera Health
SHC
$5.38B
| $380K | 0.06% |
+19,396
| New | +$406K |
|
675
Advanced Drainage Systems
WMS
$11B
| $380K | 0.06% |
+4,223
| New | +$434K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.
GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.
- GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
- GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
- GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
- GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
- GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
- GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
- GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.
Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.